Breakthrough CBD Injection Offers Long-Lasting Pain Relief for Calves
Pharmacokinetics and tolerability of liposomal synthetic cannabidiol subcutaneous depot in Holstein dairy calves.
AI Summary
This groundbreaking veterinary research explores an innovative approach to cannabidiol (CBD) administration in dairy calves, demonstrating the potential of liposomal synthetic CBD as a long-lasting pain management solution. The study investigated a subcutaneous injection method that allows for extended CBD release, addressing the traditional challenges of low oral bioavailability associated with CBD.
The researchers discovered that a single injection of 5 mg/kg liposomal synthetic CBD produced detectable plasma concentrations for up to 4.5 weeks, with a median peak concentration of 44.1 ng/mL. Notably, the primary metabolite 7-carboxy-CBD was found to exceed CBD exposure by 9-fold, suggesting complex metabolic interactions. The injection was well-tolerated by the calves, with only minor side effects like local swelling that spontaneously resolved.
While focused on animal welfare, this study provides valuable insights into advanced CBD delivery methods that could potentially translate to human medical applications. The research highlights the promising potential of liposomal technology in improving drug absorption and prolonging therapeutic effects, opening new avenues for pain management and reducing suffering in both veterinary and potentially human medical contexts.
π
Original Abstract
Related Research
Similar Studies
More Pain research papers you might find interesting.
Review finds strongest evidence in select seizure and MS symptoms
In older adults, oral THC reduced lab pain, while vaporization raisedβ¦
Survey links cannabis use with anxiety and opioid use in bleeding disorders
Explore More Research
Stay informed about the latest cannabis science.